Cargando…
Molecular docking and simulation studies of Chloroquine, Rimantadine and CAP-1 as potential repurposed antivirals for decapod iridescent virus 1 (DIV1)
Drug repurposing is a methodology of identifying new therapeutic use for existing drugs. It is a highly efficient, time and cost-saving strategy that offers an alternative approach to the traditional drug discovery process. Past in-silico studies involving molecular docking have been successful in i...
Autores principales: | Azemin, Wan-Atirah, Ishak, Nur Farahin, Saedin, Mohamad Amirul Asyraf, Shamsir, Mohd Shahir, Razali, Siti Aisyah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579962/ https://www.ncbi.nlm.nih.gov/pubmed/37854946 http://dx.doi.org/10.1016/j.fsirep.2023.100120 |
Ejemplares similares
-
Susceptibility of Exopalaemon carinicauda to the Infection with Shrimp Hemocyte Iridescent Virus (SHIV 20141215), a Strain of Decapod Iridescent Virus 1 (DIV1)
por: Chen, Xing, et al.
Publicado: (2019) -
Development and Visualization Improvement for the Rapid Detection of Decapod Iridescent Virus 1 (DIV1) in Penaeus vannamei Based on an Isothermal Recombinase Polymerase Amplification Assay
por: Xu, Yajin, et al.
Publicado: (2022) -
Integrated analysis of intestinal microbiota and metabolomic reveals that decapod iridescent virus 1 (DIV1) infection induces secondary bacterial infection and metabolic reprogramming in Marsupenaeus japonicus
por: He, Zihao, et al.
Publicado: (2022) -
Emergence of Decapod iridescent virus 1 in cultured shrimp from Taiwan in 2020
por: Yiping, Lu, et al.
Publicado: (2023) -
Host-microbiota interactions and responses of Metapenaeus ensis infected with decapod iridescent virus 1
por: Liao, Minze, et al.
Publicado: (2023)